Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 5/20 | 0.61 |
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.37 |
| ▸ | CES1 | P23141 | 2/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL6322420 | 0.93 | ACHE (0.52) | ACHETSHRLMNAALOX12ALDH1A1 | |
| Toluene SCHEMBL10624846 | 0.86 | ACHE (0.58) | ACHETSHRLMNAALOX12ALDH1A1 | |
| P-Xylene SCHEMBL19859054 | 0.85 | ACHE (0.53) | ACHETSHRLMNAALOX12ALDH1A1 | |
| Toluene SCHEMBL6431364 | 0.83 | ACHE (0.61) | ACHETSHRLMNAALOX12ALDH1A1 | |
| Toluene SCHEMBL9799867 | 0.82 | ACHE (0.79) | ACHETSHRLMNAALOX12ALDH1A1 | |
| Toluene SCHEMBL6068472 | 0.81 | ACHE (0.58) | ACHETSHRLMNAALOX12ALDH1A1 | |
| Toluene SCHEMBL7309310 | 0.81 | TSHR (0.58) | ACHETSHRLMNAALOX12ALDH1A1 | |
| Toluene SCHEMBL11594422 | 0.81 | TSHR (0.58) | ACHETSHRLMNAALOX12ALDH1A1 | |
| O-Xylene SCHEMBL3956566 | 0.80 | TSHR (0.59) | ACHETSHRALDH1A1MAPK1CA4 | |
| Toluene SCHEMBL7645369 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240092768-A1 | CRYSTAL FORM OF ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD FOR CRYSTAL FORM, AND USE OF CRYSTAL FORM | XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) | 2024-03-21 | — | — | US | claimed |
| CN-112218847-B | Method for preparing iloprost | 奇诺因药物和化学工厂私人有限公司 | 2024-03-08 | — | — | CN | claimed |
| EP-4282860-A1 | CRYSTAL FORM OF ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD FOR CRYSTAL FORM, AND USE OF CRYSTAL FORM | Sichuan Haisco Pharmaceutical Co., Ltd. (CN) | 2023-11-29 | — | — | EP | claimed |
| WO-2022156737-A1 | CRYSTAL FORM OF ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD FOR CRYSTAL FORM, AND USE OF CRYSTAL FORM | 四川海思科制药有限公司 | 2022-07-28 | — | — | WO | claimed |
| CN-112218847-A | Method for preparing iloprost | 奇诺因药物和化学工厂私人有限公司 | 2021-01-12 | — | — | CN | claimed |
| US-8053572-B2 | Alkyl-analide producing method | BAYER CROPSCIENCE AG (DE) | 2011-11-08 | — | — | US | claimed |
| US-20090209769-A1 | Alkyl-Analide Producing Method | BAYER CROPSCIENCE AG (DE) | 2009-08-20 | — | — | US | claimed |
| CN-1179770-A | Preparation of cis- 4 -0 -protected -2 -cyclopentenol derivatives | HOECHST MARION ROUSSEL INC (US) | 1998-04-22 | — | — | CN | claimed |
| US-5728899-A | Preparation of cis-4-O-protected-2-cyclopentenol derivatives | HOECHST MARION ROUSSEL INC. (US) | 1998-03-17 | — | — | US | claimed |
| EP-0817764-A1 | PREPARATION OF CIS-4-O-PROTECTED-2-CYCLOPENTENOL DERIVATIVES | HOECHST MARION ROUSSEL, INC. (US) | 1998-01-14 | — | — | EP | claimed |
| WO-1996030320-A1 | PREPARATION OF CIS-4-O-PROTECTED-2-CYCLOPENTENOL DERIVATIVES | HOECHST MARION ROUSSEL, INC. (US) | 1996-10-03 | — | — | WO | claimed |
| EP-4400498-A1 | AMORPHOUS SUBSTANCES, CRYSTALS, PHARMACEUTICAL COMPOSITIONS, PREPARATION METHODS AND USES OF THIOHYDANTOIN COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Suzhou Kintor Pharmaceuticals, Inc. (CN) | 2024-07-17 | — | — | EP | disclosed |
| CN-114163323-B | Synthesis method of 3-oxo-cyclobutanecarboxylic acid | 大连双硼医药化工有限公司 | 2024-03-26 | — | — | CN | disclosed |
| US-20240092768-A1 | CRYSTAL FORM OF ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD FOR CRYSTAL FORM, AND USE OF CRYSTAL FORM | XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) | 2024-03-21 | — | — | US | disclosed |
| CN-117355521-A | Heteroaryl inhibitors of plasma kallikrein | 武田药品工业株式会社 | 2024-01-05 | — | — | CN | disclosed |
| US-5185359-A | N-phenoxphenyloxymethyl substituted azoles and method for controlling pests therewith | BASF AKTIENGESELLSCHAFT (DE) | 1993-02-09 | — | — | US | disclosed |
| US-5116860-A | N-SUBSTITUTED AZOLES FOR COMBATING INSECTS, ARACHNIDS AND NEMATODES | BASF AKTIENGESELLSCHAFT (DE) | 1992-05-26 | — | — | US | disclosed |
| EP-0471833-A1 | METHOD FOR INCREASING THE ALPHA TO BETA RATIO IN AN ASPARTAME COUPLING REACTION. | NUTRASWEET CO (US) | 1992-02-26 | — | — | EP | disclosed |
| WO-1991013860-A1 | METHOD FOR INCREASING THE ALPHA TO BETA RATIO IN AN ASPARTAME COUPLING REACTION | THE NUTRASWEET COMPANY (US) | 1991-09-19 | — | — | WO | disclosed |
| US-4943585-A | N-substituted azoles and insecticide, arachnicide, and nematocide compositions thereof | BASF AKTIENGESELLSCHAFT (DE) | 1990-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240092768-A1 | CRYSTAL FORM OF ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD FOR CRYSTAL FORM, AND USE OF CRYSTAL FORM | ZC3HAV1, ZC3HAV1L, FMNL1 | ACHE 4258/4885TSHR 1267/4885LMNA 408/4885 |
| US-20090209769-A1 | Alkyl-Analide Producing Method | CYP51A1, CYP4X1, CYP2B6 | ACHE 1708/4885TSHR 4472/4885LMNA 2861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.